AMN Healthcare AMN Restricted Marketable Securities
Restricted Marketable Securities at other companies
Other financials
Where this comes from
Reported directly by AMN Healthcare in its filing.
Tagged under the XBRL concept us-gaap:RestrictedInvestments.
The official record: AMN Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AMN Healthcare's restricted marketable securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AMN Healthcare's restricted marketable securities?
- AMN Healthcare (AMN) reported restricted marketable securities of $34.1M in Q1 2026.
- How has AMN Healthcare's restricted marketable securities changed year-over-year?
- AMN Healthcare's restricted marketable securities increased by 50.0% year-over-year, from $22.73M to $34.1M.
- What is the long-term trend for AMN Healthcare's restricted marketable securities?
- Over 5 years (2020 to 2025), AMN Healthcare's restricted marketable securities has grown at a 6.2% compound annual growth rate (CAGR), from $25.2M to $34.04M.